Enveric Biosciences, Inc. (ENVB)

Enveric Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	4	3	4	29	8	6
Market Cap Growth	110.89%	-30.19%	-85.19%	265.82%	40.49%	-17.79%
Enterprise Value	-3	1	-13	12	6	6
PE Ratio	-	-0.17	-0.23	-0.60	-1.16	-2.36
PB Ratio	0.58	1.54	0.30	1.31	2.34	-3.13
P/FCF Ratio	-0.63	-0.21	-0.24	-2.51	-2.05	-8.77
P/OCF Ratio	-0.63	-0.21	-0.25	-2.55	-2.05	-8.77
EV/EBITDA Ratio	-0.06	-0.04	0.68	-0.22	-1.02	-2.74
EV/EBIT Ratio	-0.06	-0.04	0.67	-0.21	-1.00	-2.74
EV/FCF Ratio	-0.08	-0.05	0.75	-1.03	-1.65	-9.84
Debt / Equity Ratio	-	-	0.00	0.01	-	-0.41
Debt / EBITDA Ratio	-	-	0.00	0.00	-	-0.32
Debt / FCF Ratio	-	-	0.00	-0.02	-	-1.14
Quick Ratio	2.68	0.98	4.44	6.34	2.32	0.02
Current Ratio	3.48	1.53	4.61	6.48	3.35	0.06
Interest Coverage	-	-	-3801.13	-5469.31	-14.42	-28.46
Return on Equity (ROE)	-383.90%	-355.00%	-89.60%	-169.60%	-69.20%	-28.80%
Return on Assets (ROA)	-204.50%	-191.00%	-67.70%	-134.20%	-31.70%	-11.10%
Return on Capital (ROIC)	-216.99%	-840.78%	-186.04%	-287.44%	-164.46%	214.38%
Earnings Yield	-404.34%	-578.54%	-434.91%	-167.81%	-86.04%	-42.45%
FCF Yield	-308.68%	-466.67%	-410.17%	-39.91%	-48.74%	-11.41%
Buyback Yield / Dilution	-92.54%	-49.31%	-206.13%	-310.48%	-8.82%	-2122.43%
Total Shareholder Return	-92.54%	-49.31%	-206.13%	-310.48%	-8.82%	-2122.43%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).